Production (Stage)
Acuren Corporation
TIC
$10.47
-$0.13-1.23%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 234.22M | 262.04M | 303.00M | 266.18M | 223.06M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 234.22M | 262.04M | 303.00M | 266.18M | 223.06M |
| Cost of Revenue | 190.55M | 207.57M | 228.28M | 197.94M | 167.21M |
| Gross Profit | 43.67M | 54.48M | 74.72M | 68.23M | 55.85M |
| SG&A Expenses | 52.46M | 47.21M | 121.74M | 51.36M | 41.85M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 243.00M | 254.77M | 350.02M | 249.31M | 209.07M |
| Operating Income | -8.79M | 7.27M | -47.02M | 16.87M | 13.99M |
| Income Before Tax | -24.33M | -19.52M | -104.12M | 239.00K | -1.98M |
| Income Tax Expenses | 1.47M | 9.03M | -18.24M | 3.60M | -710.00K |
| Earnings from Continuing Operations | -25.79M | -28.55M | -85.88M | -3.36M | -1.27M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -25.79M | -28.55M | -85.88M | -3.36M | -1.27M |
| EBIT | -8.79M | 7.27M | -47.02M | 16.87M | 13.99M |
| EBITDA | 19.81M | 34.15M | -19.58M | 36.25M | 33.09M |
| EPS Basic | -0.21 | -0.24 | -1.01 | -0.67 | -0.25 |
| Normalized Basic EPS | -0.12 | -0.04 | -0.48 | 0.03 | -0.25 |
| EPS Diluted | -0.21 | -0.24 | -1.01 | -0.67 | -0.25 |
| Normalized Diluted EPS | -0.12 | -0.04 | -0.48 | 0.03 | -0.25 |
| Average Basic Shares Outstanding | 121.48M | 121.48M | 85.31M | 5.02M | 5.02M |
| Average Diluted Shares Outstanding | 122.48M | 121.48M | 85.31M | 5.02M | 5.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |